Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.828 |
Intermediate Similarity |
NPD4374 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD1722 |
Approved |
0.8158 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD4128 |
Approved |
0.8072 |
Intermediate Similarity |
NPD2390 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD2837 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4181 |
Approved |
0.8 |
Intermediate Similarity |
NPD786 |
Approved |
0.7965 |
Intermediate Similarity |
NPD1895 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD2007 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD4637 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD715 |
Phase 3 |
0.7937 |
Intermediate Similarity |
NPD3100 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD4547 |
Phase 3 |
0.787 |
Intermediate Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD975 |
Approved |
0.7853 |
Intermediate Similarity |
NPD976 |
Approved |
0.7853 |
Intermediate Similarity |
NPD977 |
Approved |
0.7799 |
Intermediate Similarity |
NPD1918 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD4902 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD4615 |
Phase 2 |
0.7751 |
Intermediate Similarity |
NPD4779 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD2333 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD992 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD991 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD1313 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2006 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD1853 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD2430 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD1683 |
Approved |
0.7701 |
Intermediate Similarity |
NPD6277 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD7111 |
Discontinued |
0.7684 |
Intermediate Similarity |
NPD706 |
Phase 1 |
0.7679 |
Intermediate Similarity |
NPD3323 |
Discontinued |
0.7677 |
Intermediate Similarity |
NPD3385 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1661 |
Suspended |
0.7647 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD1598 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD4047 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD3476 |
Approved |
0.7597 |
Intermediate Similarity |
NPD3475 |
Approved |
0.7596 |
Intermediate Similarity |
NPD3830 |
Phase 1 |
0.759 |
Intermediate Similarity |
NPD2748 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD2927 |
Phase 3 |
0.7572 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7561 |
Intermediate Similarity |
NPD2172 |
Phase 1 |
0.7558 |
Intermediate Similarity |
NPD6828 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD6469 |
Phase 3 |
0.7554 |
Intermediate Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1192 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1262 |
Discovery |
0.7529 |
Intermediate Similarity |
NPD509 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD2118 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2119 |
Approved |
0.7515 |
Intermediate Similarity |
NPD1015 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD1016 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD2385 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD966 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5418 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD5436 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD6721 |
Phase 1 |
0.7486 |
Intermediate Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2150 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD5892 |
Approved |
0.747 |
Intermediate Similarity |
NPD1917 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD4463 |
Approved |
0.7455 |
Intermediate Similarity |
NPD4462 |
Approved |
0.7446 |
Intermediate Similarity |
NPD6278 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7394 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD2641 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2640 |
Approved |
0.7436 |
Intermediate Similarity |
NPD803 |
Phase 1 |
0.743 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD2751 |
Phase 1 |
0.7429 |
Intermediate Similarity |
NPD2406 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD1333 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD1002 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD6595 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD3506 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3505 |
Approved |
0.7384 |
Intermediate Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD1215 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD1248 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7469 |
Discontinued |
0.7363 |
Intermediate Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD1708 |
Approved |
0.736 |
Intermediate Similarity |
NPD1707 |
Approved |
0.7356 |
Intermediate Similarity |
NPD3610 |
Approved |
0.7356 |
Intermediate Similarity |
NPD3609 |
Approved |
0.7353 |
Intermediate Similarity |
NPD1403 |
Approved |
0.7353 |
Intermediate Similarity |
NPD1404 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3486 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD3961 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD4076 |
Approved |
0.7345 |
Intermediate Similarity |
NPD4079 |
Approved |
0.7345 |
Intermediate Similarity |
NPD40 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD5730 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD4028 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4029 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3942 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3944 |
Approved |
0.7342 |
Intermediate Similarity |
NPD4030 |
Approved |
0.7338 |
Intermediate Similarity |
NPD9583 |
Approved |
0.733 |
Intermediate Similarity |
NPD4075 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD2720 |
Phase 1 |
0.7326 |
Intermediate Similarity |
NPD2719 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD2391 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD1332 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD45 |
Approved |
0.7312 |
Intermediate Similarity |
NPD5462 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6554 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2880 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD3654 |
Approved |
0.7303 |
Intermediate Similarity |
NPD702 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD4024 |
Phase 3 |
0.7293 |
Intermediate Similarity |
NPD2793 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD7026 |
Phase 2 |
0.7288 |
Intermediate Similarity |
NPD6203 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD3943 |
Clinical (unspecified phase) |
0.7284 |
Intermediate Similarity |
NPD1395 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD6794 |
Approved |
0.7278 |
Intermediate Similarity |
NPD473 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2580 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD4891 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD2012 |
Clinical (unspecified phase) |
0.7258 |
Intermediate Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD1253 |
Approved |
0.725 |
Intermediate Similarity |
NPD1255 |
Approved |
0.725 |
Intermediate Similarity |
NPD1254 |
Approved |
0.725 |
Intermediate Similarity |
NPD1256 |
Approved |
0.7249 |
Intermediate Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD4638 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4640 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4639 |
Approved |
0.7238 |
Intermediate Similarity |
NPD4298 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD268 |
Approved |
0.7237 |
Intermediate Similarity |
NPD271 |
Approved |
0.7237 |
Intermediate Similarity |
NPD270 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD9598 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD2865 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD3348 |
Phase 2 |
0.7231 |
Intermediate Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD768 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6285 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD2165 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD809 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD8026 |
Phase 1 |
0.7209 |
Intermediate Similarity |
NPD6771 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD5315 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD9357 |
Approved |
0.7207 |
Intermediate Similarity |
NPD5962 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD7618 |
Phase 3 |
0.7204 |
Intermediate Similarity |
NPD7619 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD1257 |
Approved |
0.7198 |
Intermediate Similarity |
NPD5820 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD947 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD2639 |
Approved |
0.7184 |
Intermediate Similarity |
NPD2642 |
Approved |
0.7182 |
Intermediate Similarity |
NPD4957 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD6178 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD3112 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3114 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3115 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3113 |
Approved |
0.7174 |
Intermediate Similarity |
NPD2818 |
Discontinued |
0.7173 |
Intermediate Similarity |
NPD2364 |
Suspended |
0.7166 |
Intermediate Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD5934 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD2310 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5254 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD1893 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD1892 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD6454 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD1327 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2185 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD490 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4326 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD6664 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4550 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3889 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4702 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4703 |
Approved |
0.712 |
Intermediate Similarity |
NPD3015 |
Discontinued |
0.7117
|
Intermediate Similarity |
NPD174 |
Discontinued |